0001127602-13-014777.txt : 20130430
0001127602-13-014777.hdr.sgml : 20130430
20130430172110
ACCESSION NUMBER: 0001127602-13-014777
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130426
FILED AS OF DATE: 20130430
DATE AS OF CHANGE: 20130430
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCNAMEE BRIAN M
CENTRAL INDEX KEY: 0001183885
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-12477
FILM NUMBER: 13799090
MAIL ADDRESS:
STREET 1: AMGEN INC.
STREET 2: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320-1799
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMGEN INC
CENTRAL INDEX KEY: 0000318154
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 953540776
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
BUSINESS PHONE: (805)447-1000
MAIL ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
FORMER COMPANY:
FORMER CONFORMED NAME: AMGEN
DATE OF NAME CHANGE: 19870305
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2013-04-26
0000318154
AMGEN INC
AMGN
0001183885
MCNAMEE BRIAN M
ONE AMGEN CENTER DRIVE
THOUSAND OAKS
CA
91320-1799
1
SVP, Human Resources
Common Stock
2013-04-26
4
M
0
10000
58.43
A
66077
D
Common Stock
2013-04-26
4
S
0
10000
107.9872
D
56077
D
Common Stock
2013-04-26
4
F
0
723
108.66
D
55354
D
Common Stock
2013-04-28
4
F
0
711
108.38
D
54643
D
Common Stock
2013-04-29
4
M
0
10000
50.44
A
64643
D
Common Stock
2013-04-29
4
S
0
10000
107.0191
D
54643
D
Nqso (Right to Buy)
58.43
2013-04-26
4
M
0
10000
0
D
2011-04-26
2020-04-26
Common Stock
10000
10000
D
Nqso (Right to Buy)
50.44
2013-04-29
4
M
0
10000
0
D
2010-04-28
2016-04-28
Common Stock
10000
0
D
The price reported is an average price. The prices ranged from $107.96 to $108.00 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC, the issuer or a security holder of the issuer.
The price reported is an average price. The prices ranged from $106.8707 to $107.1316 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC, the issuer or a security holder of the issuer.
These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,450 RSUs which fully vest on 4/26/2014; 22,081 RSUs which fully vest on 12/31/2014; 5,025 RSUs which vest in one installment of 2,475 on 4/25/2014 and one installment of 2,550 on 4/25/2015; 4,466 RSUs which vest in three installments of 1,473, 1,474 and 1,519 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; and 4,439 RSUs which vest in three installments of 1,464, 1,465 and 1,510 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
These shares include 106 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
/s/ Andrea Robinson, Attorney-in-Fact for Mr. McNamee
2013-04-30